About inbiome
inbiome is a company based in Amsterdam (Netherlands) founded in 2019. inbiome offers products and services including Molecular Culture® and Microbiology services. inbiome operates in a competitive market with competitors including Medeloop, Hyku Biosciences, Sirion Biotech, Metagen Therapeutics and Taizhou Baiying Biotechnology, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.76 M (USD), Grant
Jun 01, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of inbiome
inbiome offers a comprehensive portfolio of products and services, including Molecular Culture® and Microbiology services.
Enables fast and accurate detection of bacteria for healthcare diagnostics.
Offers bacterial identification and analysis for research and clinical use.
Funding Insights of inbiome
Investors in inbiome
inbiome has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for inbiome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by inbiome
Investment portfolio details for inbiome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - inbiome
Detailed financials for inbiome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inbiome Comparisons
Peer comparison for inbiome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of inbiome
inbiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medeloop, Hyku Biosciences, Sirion Biotech, Metagen Therapeutics and Taizhou Baiying Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery services are offered by Medeloop as a CRO.
|
|
| Locked | Locked | Locked |
Covalent medicines platform is advanced for drug discovery targeting proteins.
|
|
| Locked | Locked | Locked |
Customized AAV-based viral vectors for gene therapy are supplied.
|
|
| Locked | Locked | Locked |
CRO focused on providing microbiome drug discovery and development services
|
|
| Locked | Locked | Locked |
Antibody-drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical and biotech clients.
|
Detailed competitors of inbiome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inbiome
Complete news archive for inbiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about inbiome
inbiome was founded in 2019 and raised its 1st funding round 4 years after it was founded.
inbiome is headquartered in Amsterdam, Netherlands.
Inbiome was established in 2019 and is based in Amsterdam, Netherlands. As a contract research organization in the biotechnology sector, focus is placed on molecular culture development. Research services are delivered to support microbial analysis and innovation for clients. Operations emphasize precise culturing methods and experimental protocols within the life sciences domain.
inbiome's top competitors include Medeloop, Pure Biologics and Centivax.
inbiome offers Molecular Culture® and Microbiology services.
inbiome has 1 investor. Key investors include EIC Fund.